Literature DB >> 23947356

Virus infection, antiviral immunity, and autoimmunity.

Daniel R Getts1, Emily M L Chastain, Rachael L Terry, Stephen D Miller.   

Abstract

As a group of disorders, autoimmunity ranks as the third most prevalent cause of morbidity and mortality in the Western World. However, the etiology of most autoimmune diseases remains unknown. Although genetic linkage studies support a critical underlying role for genetics, the geographic distribution of these disorders as well as the low concordance rates in monozygotic twins suggest that a combination of other factors including environmental ones are involved. Virus infection is a primary factor that has been implicated in the initiation of autoimmune disease. Infection triggers a robust and usually well-coordinated immune response that is critical for viral clearance. However, in some instances, immune regulatory mechanisms may falter, culminating in the breakdown of self-tolerance, resulting in immune-mediated attack directed against both viral and self-antigens. Traditionally, cross-reactive T-cell recognition, known as molecular mimicry, as well as bystander T-cell activation, culminating in epitope spreading, have been the predominant mechanisms elucidated through which infection may culminate in an T-cell-mediated autoimmune response. However, other hypotheses including virus-induced decoy of the immune system also warrant discussion in regard to their potential for triggering autoimmunity. In this review, we discuss the mechanisms by which virus infection and antiviral immunity contribute to the development of autoimmunity.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T-cell receptor affinity; autoimmune disease; bystander activation; epitope spreading; microbial superantigens; molecular mimicry

Mesh:

Year:  2013        PMID: 23947356      PMCID: PMC3971377          DOI: 10.1111/imr.12091

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  163 in total

1.  Molecular and cellular mechanisms for microbial entry into the CNS.

Authors:  J R Zhang; E Tuomanen
Journal:  J Neurovirol       Date:  1999-12       Impact factor: 2.643

Review 2.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

Review 3.  Interaction of viruses with host cell molecular motors.

Authors:  Ming Je Hsieh; Paul J White; Colin W Pouton
Journal:  Curr Opin Biotechnol       Date:  2010-07-16       Impact factor: 9.740

4.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

Authors:  Eileen J McMahon; Samantha L Bailey; Carol Vanderlugt Castenada; Hanspeter Waldner; Stephen D Miller
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

5.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

Authors:  A E Lovett-Racke; J L Trotter; J Lauber; P J Perrin; C H June; M K Racke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

6.  Multiple sclerosis after infectious mononucleosis.

Authors:  Trine Rasmussen Nielsen; Klaus Rostgaard; Nete Munk Nielsen; Nils Koch-Henriksen; Sven Haahr; Per Soelberg Sørensen; Henrik Hjalgrim
Journal:  Arch Neurol       Date:  2007-01

7.  Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control.

Authors:  Parul Kapil; Roscoe Atkinson; Chandran Ramakrishna; Daniel J Cua; Cornelia C Bergmann; Stephen A Stohlman
Journal:  J Virol       Date:  2009-04-01       Impact factor: 5.103

8.  A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model.

Authors:  Allison C German; Khin Saw Aye Myint; Nguyen Thi Hoang Mai; Ian Pomeroy; Nguyen Hoan Phu; John Tzartos; Peter Winter; Jennifer Collett; Jeremy Farrar; Alan Barrett; Anja Kipar; Margaret M Esiri; Tom Solomon
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-06-30       Impact factor: 2.184

9.  Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease.

Authors:  C F Evans; M S Horwitz; M V Hobbs; M B Oldstone
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

10.  Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.

Authors:  K W Wucherpfennig; A Sette; S Southwood; C Oseroff; M Matsui; J L Strominger; D A Hafler
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  87 in total

1.  Viral Nanoparticles: Cancer Vaccines and Immune Modulators.

Authors:  Manlio Fusciello; Erkko Ylösmäki; Vincenzo Cerullo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes.

Authors:  Junbao Yang; I-Ting Chow; Tomasz Sosinowski; Nadia Torres-Chinn; Carla J Greenbaum; Eddie A James; John W Kappler; Howard W Davidson; William W Kwok
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

Review 3.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 4.  The microbiome in autoimmune diseases.

Authors:  F De Luca; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2019-01       Impact factor: 4.330

Review 5.  Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.

Authors:  John B Grigg; Gregory F Sonnenberg
Journal:  J Immunol       Date:  2017-01-15       Impact factor: 5.422

Review 6.  De novo autoimmune hepatitis in liver transplant: State-of-the-art review.

Authors:  Ranka Vukotic; Giovanni Vitale; Antonia D'Errico-Grigioni; Luigi Muratori; Pietro Andreone
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 7.  Complexities in the relationship between infection and autoimmunity.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 8.  Potentiating prostate cancer immunotherapy with oncolytic viruses.

Authors:  Patrick Lee; Shashi Gujar
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

9.  Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.

Authors:  Daniel F Hoft; Kathleen Lottenbach; Johannes B Goll; Heather Hill; Patricia L Winokur; Shital M Patel; Rebecca C Brady; Wilbur H Chen; Kathryn Edwards; C Buddy Creech; Sharon E Frey; Tamara P Blevins; Rachelle Salomon; Robert B Belshe
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

10.  Molecular mimicry and clonal deletion: A fresh look.

Authors:  Noel R Rose
Journal:  J Theor Biol       Date:  2014-08-27       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.